Cargando…
Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
OBJECTIVES: To evaluate the effects of epoetin (EPO) alfa treatment on overall survival, event-free survival and response duration in patients with myelodysplastic syndrome (MDS) who were treated at a haematological referral centre in northeastern Brazil. METHODS: This was a retrospective cohort stu...
Autores principales: | Moura, Anna Thawanny Gadelha, Duarte, Fernando Barroso, Barbosa, Maritza Cavalcante, de Jesus dos Santos, Talyta Ellen, Lemes, Romélia Pinheiro Gonçalves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724462/ https://www.ncbi.nlm.nih.gov/pubmed/31508719 http://dx.doi.org/10.6061/clinics/2019/e771 |
Ejemplares similares
-
Myelodysplastic syndrome versus idiopathic cytopenia of undetermined
significance: the role of morphology in distinguishing between these
entities
por: dos Santos, Talyta Ellen de Jesus, et al.
Publicado: (2013) -
Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
por: Duarte, Fernando Barroso, et al.
Publicado: (2014) -
Idiopathic cytopenia of undetermined significance and systemic lupus
erythematosus
por: Gonçalves, Romelia Pinheiro, et al.
Publicado: (2013) -
Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
por: Duarte, Fernando Barroso, et al.
Publicado: (2017) -
Comet assay in myelodysplastic syndromes
por: Teixeira Neto, Paulo Florentino, et al.
Publicado: (2012)